Our results thus far determined an important role for A20 in GSC growth, survival, and self-renewal in vitro, but the ultimate goal of any cancer stem cell–directed therapy is to provide therapeutic benefit in vivo. The gene discussed is TNFAIP3; the disease is cancer.